RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
Republic of Korea, Cheonan
Byung-hee Lee
42 years of experience
Clinic is certified :
Diabetes mellitus treatment with stem cells in the Republic of Korea costs from AUD $26,430 to AUD $47,145. The total depends on the cell delivery method, clinic prestige, and session frequency. Patients save about 12% compared to Australia, where costs average AUD $30,001. Packages usually include specialist consultations, stem cell harvesting, laboratory processing, and the infusion session.
Bookimed Expert Insight: The Republic of Korea offers specialised delivery methods that maximise treatment value. RE:YOUTH (Yonsei BH Arterial Stemcell Clinic) uses a unique arterial method. This approach delivers cells directly to the pancreas for higher efficiency. Advanced facilities also hold KOIHA accreditation, a local safety standard for healthcare centres. Prices for these specialised protocols typically start around A$13,700 for eligible patients.
| Republic of Korea | Thailand | Turkey | |
| Diabetes mellitus treatment with stem cells | from AUD $26,430 | from AUD $21,429 | from AUD $17,144 |
No hidden fees – just official clinic prices. Pay at the clinic for Diabetes mellitus treatment with stem cells upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Diabetes mellitus treatment with stem cells and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Diabetes mellitus treatment with stem cells journey.
Dr. Byung-hee Lee is a neurosurgeon at RE:YOUTH Clinic in South Korea. He is a founding member of the Korean Society of Interventional Neurology. He also helped found the Korean Stroke Society. Dr. Lee treats complex conditions like Parkinson's, Alzheimer's, and cerebral aneurysms.
Stem cell therapy for diabetes in Korea is not a proven medical cure. Doctors in clinics like RE:YOUTH use it to improve insulin sensitivity and metabolic function. The treatment helps reduce medication reliance, but patients generally still need ongoing monitoring and management of the underlying condition.
Bookimed Expert Insight: Korea stands out because of specialised facilities like RE:YOUTH that limit intake to only 2 patients daily. This VIP approach focuses on arterial infusion rather than standard intravenous methods. The technique aims to deliver cells directly to target organs for better absorption.
Patient Consensus: Some patients achieve insulin independence for extended periods in Korea. Success often involves restoring beta cell function for those with severe, dysregulated diabetes.
Stem cell therapy for diabetes in the Republic of Korea is an evolving research field. It focuses on improving beta-cell function and managing complications. Leading facilities like RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) use direct arterial infusion. This targets islet cells, aiming to reduce insulin dependence for Type 2 patients.
Bookimed Expert Insight: While many countries offer general intravenous stem cells, Korea specialises in arterial stem cell therapy for chronic diseases. Data shows clinics like RE:YOUTH serve 1,000+ patients annually with this targeted approach. This precision delivery is rare globally. It helps concentrate regenerative power directly where the body needs it most.
Patient Consensus: Treatment in Korea focuses on long-term management rather than a quick cure. Patients often see steady improvements in energy levels and reduced neuropathy pain over 6 months.
Korean clinics primarily use autologous mesenchymal stem cells derived from fat or bone marrow for diabetes. Specialists often focus on adipose-derived stem cells or blood-derived progenitor cells. These treatments aim to manage insulin resistance and pancreatic inflammation through intensive arterial infusion protocols.
Bookimed Expert Insight: While many clinics offer adipose-derived cells, RE:YOUTH distinguishes itself by limiting intake to two daily patients. This VIP-level focus allows precision during complex arterial infusions. This technique aims for higher delivery accuracy compared to standard intravenous drips commonly used elsewhere.
Patient Consensus: Patients value how clinics combine stem cell therapy with comprehensive regenerative protocols. The use of one's own cells provides peace of mind regarding safety. The direct arterial approach is often praised for its technical sophistication in South Korea.
For diabetes, stem cell therapy in South Korea uses direct arterial infusion or intravenous injections. Mesenchymal stem cells aim to regenerate insulin-producing pancreatic cells. The process includes comprehensive lab assessments and cell harvesting from fat or bone marrow. The cells are then expanded in the lab to achieve high therapeutic counts. Clinics like RE:YOUTH specialise in arterial infusions for insulin sensitivity.
Bookimed Expert Insight: While many centres use standard intravenous drips, leading South Korean specialists prefer direct arterial infusion. This technique delivers cells specifically to the pancreatic artery. RE:YOUTH performs this procedure to maximise cell concentration where insulin production happens. This approach is rare even amongst the 75+ clinics in the region.
Patient Consensus: Patients find the process in Korea highly structured and professional. Most report that the treatment is intensive. However, the focus on direct pancreatic targeting feels much more precise than systemic injections used elsewhere.
Stem cell therapy in South Korea aims to repair biological damage caused by high blood sugar rather than just managing symptoms. The primary goals include regenerating nerve function, restoring kidney health, and promoting the healing of diabetic ulcers through arterial infusion techniques.
Bookimed Expert Insight: While most clinics offer basic intravenous therapy, the RE:YOUTH clinic in Cheonan specialises in arterial stem cell infusion. This direct delivery method ensures higher cell concentrations reach damaged organs. The facility prioritises quality by limiting treatment to only 2 patients daily.
Patient Consensus: Real experiences suggest many patients achieve reduced insulin dependence through beta-cell restoration in South Korea. The focus remains on improving daily life and preventing major complications like amputation.